Correlation of Thrombosis and Clinicohematological Parameters with JAK2V617F Mutation in Philadelphia-Negative CMPNs: A Study from India. [PDF]
Singh K +5 more
europepmc +1 more source
Prevalence of JAK2V617F mutation in women with unexplained recurrent miscarriage [PDF]
Kaandorp, S. P. +7 more
openaire +3 more sources
Clonal Hematopoiesis and JAK2V617F Mutations in Patients With Cardiovascular Disease
Tetsuro Yokokawa +8 more
openaire +2 more sources
JAK2 V617F mutation and associated chromosomal alterations in primary and secondary myelofibrosis and post-HCT outcomes. [PDF]
Rafati M +17 more
europepmc +1 more source
Author Correction: JAK2V617F mutation drives vascular resident macrophages toward a pathogenic phenotype and promotes dissecting aortic aneurysm. [PDF]
Al-Rifai R +26 more
europepmc +1 more source
Characterization of Glycoproteoforms of Integrins α2 and β1 in Megakaryocytes in the Occurrence of JAK2V617F Mutation-Induced Primary Myelofibrosis. [PDF]
Gaye MM +6 more
europepmc +1 more source
Evaluation of JAK2V617F mutation prevalence in Myeloproliferative Neoplasm by AS-RT-PCR
Background and Aim: The JAK2 is an acquired mutation that is observed in majority of patients with classical Philadelphia-negative Myeloproliferative neoplasms that include polycythemia vera (PV), essential thrombocythemia (ET), primary myelofibrosis (PMF).
B Bahar +8 more
openaire +2 more sources
Cerebral venous sinus thrombosis in polycythemia vera patients with JAK2V617F mutation. [PDF]
Shen HX +5 more
europepmc +1 more source
JAK2V617F mutation in patients with thrombosis: to screen or not to screen? [PDF]
S. G. XAVIER +4 more
openaire +1 more source

